press center press release

NASDAQ OMX Welcomes Xvivo Perfusion to First North


Stockholm, October 8 2012 — NASDAQ OMX (NASDAQ: NDAQ) announces that the trading in Xvivo Perfusion AB (short name: XVIVO) shares will commence today on First North at NASDAQ OMX Stockholm. Xvivo Perfusion, which is a spin-off company from main market listed Vitrolife AB, belongs to the Healthcare sector and is the sixth new company to be admitted to trading on First North in 2012.

Xvivo Perfusion is a medical technology company focused on developing optimized solutions for organ and tissue preservation in connection with transplantation. The company delivers solutions and systems that can increase organ availability, improve the transplant process outcome and enhance the long-term outcomes and quality of life of the transplant recipient.

Magnus Nilsson, CEO of Xvivo Perfusion, said: “Through our listing at First North we expect to gain increased and more focused exposure for our unique solutions towards both private and institutional investors. We operate in a market with tremendous potential and look forward to leveraging our public listing in order to build our brand and support continued financial growth.”

Emelie Jarnesten, head of NASDAQ OMX First North, commented: “We welcome Xvivo Perfusion to First North, one of Europe’s most liquid growth markets. The company is a welcome addition to the Healthcare sector and we look forward to supporting them by maximizing its exposure to both local and global investor communities.”

Xvivo Perfusion has appointed Redeye as Certified Adviser.

To view a CEO interview from the Xvivo Perfusion listing ceremony click here.

About NASDAQ OMX Group

The inventor of the electronic exchange, The NASDAQ OMX Group, Inc., fuels economies and provides transformative technologies for the entire lifecycle of a trade - from risk management to trade to surveillance to clearing. In the U.S. and Europe, we own and operate 24 markets, 3 clearinghouses and 5 central securities depositories supporting equities, options, fixed income, derivatives, commodities, futures and structured products. Able to process more than 1 million messages per second at sub-40 microsecond speeds with 99.999% uptime, our technology drives more than 70 marketplaces in 50 developed and emerging countries into the future, powering 1 in 10 of the world’s securities transactions. Our award-winning data products and worldwide indexes are the benchmarks in the financial industry. Home to approximately 3,400 listed companies worth $6 trillion in market cap whose innovations shape our world, we give the ideas of tomorrow access to capital today. Welcome to where the world takes a big leap forward, daily. Welcome to the NASDAQ OMX Century. To learn more, visit Follow us on Facebook ( and Twitter ( (Symbol: NDAQ and member of S&P 500)

Cautionary Note Regarding Forward-Looking Statements

The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about NASDAQ OMX's products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond NASDAQ OMX's control. These factors include, but are not limited to factors detailed in NASDAQ OMX's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements.

Media contact:

Carl Norell

+46 8 405 66 39

In This Story

Nasdaq Press Center

Read the latest press releases, request a press kit, and get in touch with our press team.

learn more